Harrow Health, Inc. (NASDAQ:HROW) will be hosting a conference call at 5:00 PM eastern time on 10th August 2020, to discuss its 2Q20 financial results with the investment community.
A live webcast with presentations will be available on the Internet by visiting the Company website www.harrowinc.com
Earnings Expectation
Harrow Health, Inc. is set to announce second quarter earning results on Monday 10th August 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, HROW to report 2Q20 loss of $ 0.1 per share from revenue of $ 5.70 million. For the full year, analysts anticipate top line of $ 35.84 million, while looking forward to loss of $ 0.77 per share bottom line.
Harrow Health, Inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the United States. The company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. It also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.
